Literature DB >> 1376965

Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments.

B Knebelmann1, G Deschenes, F Gros, M C Hors, J P Grünfeld, J Zhou, K Tryggvason, M C Gubler, C Antignac.   

Abstract

A large kindred with adult-type X-linked Alport syndrome was studied with regard to a defect in the recently described COL4A5 collagen gene. Southern blot analysis with COL4A5 cDNA probes showed loss of a MspI restriction site. Direct sequencing of cDNA amplified from lymphoblast mRNA demonstrated a single-base substitution converting a glycine codon to arginine at position 325 in the alpha 5 chain of type IV collagen. The triple-helical collagenous domain of alpha 5(IV), characterized by a Gly-X-Y repeat sequence, is interrupted 22 times by noncollagenous sequences. The mutation creates an additional interruption in the Gly-X-Y repeat motif, between interruptions 4 and 5. It is interesting that such glycine substitutions inside the COL1A1 or COL1A2 genes have been associated with many cases of osteogenesis imperfecta. This gly325-to-arg substitution presumably alters the triple-helix formation, and, in turn, modifies the ultrastructural and functional characteristics of the type IV collagen network inside the glomerular basement membrane.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376965      PMCID: PMC1682875     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome.

Authors:  B Knebelmann; L Boussin; D Guerrier; L Legeai; A Kahn; N Josso; J Y Picard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Localization of the Goodpasture epitope to a novel chain of basement membrane collagen.

Authors:  R J Butkowski; J P Langeveld; J Wieslander; J Hamilton; B G Hudson
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

3.  Identification of mutations in the COL4A5 collagen gene in Alport syndrome.

Authors:  D F Barker; S L Hostikka; J Zhou; L T Chow; A R Oliphant; S C Gerken; M C Gregory; M H Skolnick; C L Atkin; K Tryggvason
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

4.  Localization of the gene for classic Alport syndrome.

Authors:  F A Flinter; S Abbs; M Bobrow
Journal:  Genomics       Date:  1989-04       Impact factor: 5.736

5.  Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis.

Authors:  C Kashtan; A J Fish; M Kleppel; K Yoshioka; A F Michael
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

6.  Illegitimate transcription: transcription of any gene in any cell type.

Authors:  J Chelly; J P Concordet; J C Kaplan; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  An anonymous single copy X-chromosome clone DXS94 from Xq11-q21 identifies a common RFLP.

Authors:  G Davatelis; M Siniscalco; P Szabo
Journal:  Nucleic Acids Res       Date:  1987-06-11       Impact factor: 16.971

8.  Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome.

Authors:  S L Hostikka; R L Eddy; M G Byers; M Höyhtyä; T B Shows; K Tryggvason
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

9.  Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen.

Authors:  M M Kleppel; C Kashtan; P A Santi; J Wieslander; A F Michael
Journal:  Lab Invest       Date:  1989-09       Impact factor: 5.662

10.  The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots.

Authors:  P M Green; A J Montandon; D R Bentley; R Ljung; I M Nilsson; F Giannelli
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

View more
  16 in total

1.  Alport syndrome: a genetic study of 31 families.

Authors:  R M'Rad; M Sanak; G Deschenes; J Zhou; C Bonaiti-Pellie; L Holvoet-Vermaut; S Heuertz; M C Gubler; M Broyer; J P Grunfeld
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

2.  Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome.

Authors:  R Vargas-Poussou; D Feldmann; M Vollmer; M Konrad; L Kelly; L P van den Heuvel; L Tebourbi; M Brandis; L Karolyi; S C Hebert; H H Lemmink; G Deschênes; F Hildebrandt; H W Seyberth; L M Guay-Woodford; N V Knoers; C Antignac
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 3.  The triple helix of collagens - an ancient protein structure that enabled animal multicellularity and tissue evolution.

Authors:  Aaron L Fidler; Sergei P Boudko; Antonis Rokas; Billy G Hudson
Journal:  J Cell Sci       Date:  2018-04-09       Impact factor: 5.285

4.  Small frameshift deletions within the COL4A5 gene in juvenile-onset Alport syndrome.

Authors:  A Renieri; M Seri; L Galli; P Cosci; E Imbasciati; L Massella; G Rizzoni; G Restagno; A O Carbonara; E Stramignoni
Journal:  Hum Genet       Date:  1993-10       Impact factor: 4.132

5.  Outcomes of male patients with Alport syndrome undergoing renal replacement therapy.

Authors:  Johanna Temme; Anneke Kramer; Kitty J Jager; Katharina Lange; Frederick Peters; Gerhard-Anton Müller; Reinhard Kramar; James G Heaf; Patrik Finne; Runolfur Palsson; Anna V Reisæter; Andries J Hoitsma; Wendy Metcalfe; Maurizio Postorino; Oscar Zurriaga; Julio P Santos; Pietro Ravani; Faical Jarraya; Enrico Verrina; Friedo W Dekker; Oliver Gross
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 8.237

6.  Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele.

Authors:  C Guo; B Van Damme; Y Vanrenterghem; K Devriendt; J J Cassiman; P Marynen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Versican gene expression in human articular cartilage and comparison of mRNA splicing variation with aggrecan.

Authors:  J Grover; P J Roughley
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

8.  Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.

Authors:  Stefanie Weber; Katja Strasser; Sabine Rath; Achim Kittke; Sonja Beicht; Martin Alberer; Bärbel Lange-Sperandio; Peter F Hoyer; Marcus R Benz; Sabine Ponsel; Lutz T Weber; Hanns-Georg Klein; Julia Hoefele
Journal:  Pediatr Nephrol       Date:  2016-01-25       Impact factor: 3.714

9.  Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young.

Authors:  F Sun; B Knebelmann; M E Pueyo; H Zouali; S Lesage; M Vaxillaire; P Passa; D Cohen; G Velho; C Antignac
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.

Authors:  C Antignac; B Knebelmann; L Drouot; F Gros; G Deschênes; M C Hors-Cayla; J Zhou; K Tryggvason; J P Grünfeld; M Broyer
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.